Site Logo
  • Contact Us
  • LinkedIn
  • Twitter
  • About Stoke
    • Overview
    • Leadership
    • Founders
    • Corporate Responsibility
  • Scientific Platform
    • Overview
    • TANGO
    • Publications
  • Disease Areas
    • Overview
    • Dravet Syndrome
    • ADOA
    • SYNGAP1
    • Pipeline
  • Patients & Families
    • Overview
    • Clinical Studies
      • Expanded Access Policy
    • Educational Resources
  • Careers & Culture
    • Overview
    • Job Opportunities
    • Diversity, Inclusion & Belonging
  • Investors & News
    • Overview
    • Media Room
      • In the News
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
    • Settlement Information
  • About Stoke
    • Overview
    • Leadership
    • Founders
    • Corporate Responsibility
  • Scientific Platform
    • Overview
    • TANGO
    • Publications
  • Disease Areas
    • Overview
    • Dravet Syndrome
    • ADOA
    • SYNGAP1
    • Pipeline
  • Patients & Families
    • Overview
    • Clinical Studies
      • Expanded Access Policy
    • Educational Resources
  • Careers & Culture
    • Overview
    • Job Opportunities
    • Diversity, Inclusion & Belonging
  • Investors & News
    • Overview
    • Media Room
      • In the News
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
    • Settlement Information
  • Contact Us
  • Home
  • About Stoke
  • Leadership

Leadership

Our leadership team has deep experience and a track record of success to guide our people and our work.

Ian F. Smith

Interim Chief Executive Officer & Director

Jonathan Allan, J.D.

General Counsel

Isabel Aznarez, Ph.D.

Senior Vice President, Head of Research
and Co-Founder

Jason Hoitt

Chief Commercial Officer

Dawn Kalmar

Chief Communications Officer

Tommy Leggett

Chief Financial Officer

Eric Olson

Chief Business Officer

Barry S. Ticho, M.D., Ph.D., FACC

Chief Medical Officer

Joan Wood

Chief Human Resources Officer

Board of Directors

Ian F. Smith

Interim Chief Executive Officer & Director

Arthur Tzianabos, Ph.D.

Chairman & Interim Executive Chairman

Adrian Krainer, Ph.D.

Co-founder & Director

Jennifer Burstein, MBA, CPA

Director

Seth L. Harrison, M.D.

Director

Edward M. Kaye, M.D.

Director

Arthur Levin, Ph.D.

Director

Garry E. Menzel, Ph.D., MBA

Director

Julie Anne Smith

Director

Stoked By Science

Our story began in the lab with our founders, who shared a passion to address genetic diseases.

Learn More
  • About Stoke
  • Scientific Platform
  • Disease Areas
  • Patients & Families
  • Careers & Culture
  • Investors & News
  • Contact Us
Stoke Logo

© 2025 Stoke Therapeutics, all rights reserved.

  • Privacy Policy
  • Terms of Use
  • Cookie Policy
  • Sitemap
  • LinkedIn
  • Twitter